The US Food and Drug Administration (FDA) has approved Abbott’s FreeStyle Libre Flash Glucose Monitoring System for adults with diabetes.

The new personal continuous glucose monitor (CGM) is intended as a replacement for blood glucose monitoring (BGM) and does not require the standard finger sticks or their calibration.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The system is designed to read the glucose levels through a long-lasting personal glucose sensor that can be self-applied on the back of the upper arm for up to ten days.

Abbott Diabetes Care senior vice-president Jared Watkin said: “Today, we are celebrating a breakthrough moment for people with diabetes in the US – an end to the worry and hassles associated with routine finger sticks, which have been the standard of glucose testing for more than 40 years.

“At Abbott, we believe that FreeStyle Libre will transform diabetes management.”

“We are celebrating a breakthrough moment for people with diabetes in the US.”

FreeStyle Libre allows patients to capture real-time readings even through clothing by scanning a small hand-held reader over the water-resistant sensor.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The data obtained from the system delivers a visual snapshot of a person’s glucose fluctuations called an Ambulatory Glucose Profile (AGP) that provides information on glucose level trends.

Patients and their doctors can also review the glucose history, allowing them to make better diabetes management decisions.

Findings from clinical trials and real-world studies in a total of more than 50,000 patients revealed that FreeStyle Libre enables more frequent testing.

Image: FreeStyle Libre is now approved for adults with diabetes in the US. Photo: courtesy of PRNewsfoto/Abbott.